Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100
Closed -$1.08K 3852
2024
Q2
$1.08K Sell
100
-589
-85% -$7.25K ﹤0.01% 3454
2024
Q1
$9.65K Buy
+689
New +$8.95K ﹤0.01% 2898
2023
Q2
Sell
-234
Closed -$1.98K 3520
2023
Q1
$1.98K Hold
234
﹤0.01% 3031
2022
Q4
$2 Buy
+234
New +$1.81K ﹤0.01% 3933
2022
Q2
Sell
-10,583
Closed -$119K 1582
2022
Q1
$119K Sell
10,583
-8,724
-45% -$74.4K ﹤0.01% 1074
2021
Q4
$126K Sell
19,307
-1,184
-6% -$8.12K ﹤0.01% 1570
2021
Q3
$156K Sell
20,491
-7,594
-27% -$78.5K ﹤0.01% 1074
2021
Q2
$355K Sell
28,085
-2,493
-8% -$27.4K 0.01% 835
2021
Q1
$397K Buy
+30,578
New +$282K 0.01% 725

Other funds holding EOLS

NewEdge Advisors's EOLS Position: Q3 2024 in Review

NewEdge Advisors sold out of Evolus (EOLS) in Q3 2024, closing a stake of 100 shares — an estimated $1.08K sold.

NewEdge Advisors first reported a position in EOLS in Q1 2021 and held it in 9 quarters. The position peaked at $397K in Q1 2021. 165 funds tracked by Wall St. Rank hold EOLS as of Q3 2024.

  • NewEdge Advisors reported no remaining Evolus position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 100 Evolus shares in Q3 2024, an estimated $1.08K.
  • NewEdge Advisors first reported a position in Evolus in Q1 2021 and held it in 9 quarters.
  • NewEdge Advisors's Evolus position peaked at $397K in Q1 2021.
  • 165 funds tracked by Wall St. Rank held Evolus as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.